Concord Drugs Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 35.56 | 16.86 | 10.08 |
| Operating Expense | 34.13 | 15.97 | 9.07 |
| Net Profit | 0.52 | 0.22 | 0.19 |
| Net Profit Margin | 1.46% | 1.30% | 1.88% |
| Earning Per Share | 0.46 | 0.16 | 0.19 |
| EBIDTA | 1.42 | 0.89 | 1.01 |
| Effective Tax Rate | 14.69% | 7.87% | 8% |
Particulars
Mar 2026
Revenue35.56
Operating Expense34.13
Net Profit0.52
Net Profit Margin1.46
Earning Per Share0.46
EBIDTA1.42
Effective Tax Rate14.69
